Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Oragenics
AddedMar 19, 2024
UpdatedJul 9, 2026
Oragenics

Oragenics

Public

Biotech company in Tampa developing bacterial-based therapies.

HQ
Tampa, FL, US
Founded
1996
Overview
Compare
Fundraising
Employees
Website

Founded in Tampa, Florida, Oragenics Inc. is a biotech company dedicated to developing innovative bacterial-based therapies. The company's core mission is to address unmet medical needs through cutting-edge research and development. Oragenics focuses on creating antibiotics for infectious diseases and has expanded its portfolio to include NT-CoV2-1, an intranasal vaccine candidate for COVID-19. Additionally, the company is working on LPT3-04, a weight loss candidate, and SMaRT Replacement Therapy, a topical treatment aimed at preventing dental caries.

Oragenics has garnered attention from notable investors and industry experts, contributing to its growing reputation in the biotech field. The company has achieved significant milestones, including advancing its vaccine candidate for COVID-19 and securing funding for its various research initiatives. Through its innovative approach and commitment to addressing critical health issues, Oragenics has made a substantial impact on the medical community, particularly in the areas of infectious disease and dental health.

Oragenics - Similar Companies

Oral Genome logo

Oral Genome

oralgenome.com

Oralucent logo

Oralucent

oralucent.com

Petragen logo

Petragen

petragen.com

Biolectrics logo

Biolectrics

Orna Therapeutics logo

Orna Therapeutics

Polybiotics logo

Polybiotics

Orpro Therapeutics logo

Orpro Therapeutics

Oricula Therapeutics logo

Oricula Therapeutics

oricularx.com

Orig3N logo

Orig3N

orig3n.com

Revagenix logo

Revagenix

revagenix.com

PhagePro logo

PhagePro

phageproinc.com

Bristle logo

Bristle

bristlehealth.com

Okogen logo

Okogen

okogen.com

Ocugen logo

Ocugen

ocugen.com

ACT Biotech logo

ACT Biotech

Oragenics - Quick Facts

Who are Oragenics' competitors?

Companies similar to Oragenics include Oral Genome, Oralucent, Petragen and Biolectrics.

When was Oragenics founded?

Oragenics was founded in 1996.

Where is Oragenics' headquarters located?

Oragenics' headquarters is located in Tampa, FL, US.

When was Oragenics' last funding round?

Oragenics' most recent funding round was for $840k (USD) in August 2023.

How much has Oragenics raised to-date?

As of Aug 7, 2023, Oragenics has raised a total of $99.7M (USD).

How many employees does Oragenics have?

Oragenics has 5 employees as of Feb 6, 2024.

Oragenics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Antibiotics
  • Vaccines
Tags
  • Healthtech
Unique IDs
  • ein: 593410522
  • secCik: 0001174940
  • ticker: OGEN
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621200Offices of Dentists
  • 621210Offices of Dentists
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8020Offices And Clinics Of Dentists
  • 8021Offices And Clinics Of Dentists
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering